At a glance
ClinicalIndex Comparison Record- ✓Pathologically proven squamous cell carcinoma of oral cavity sites (tongue, floor of mouth, lip, buccal mucosa, alveolar ridge, retromolar gingiva, hard palate)
- ✓Stage T1-2N0M0 per AJCC 8th edition
- ✓History/physical examination within 42 days prior to registration
- ✓Head and neck imaging (PET/CT, contrast CT, MRI, or ultrasound) within 42 days prior to registration
- ✕Clinical or radiologic evidence of regional or distant metastatic disease
- ✕Prior non-head and neck invasive malignancy unless disease-free ≥2 years (except non-melanomatous skin cancer or in situ breast/cervix carcinoma)
- ✕Head and neck SCC in oropharynx, nasopharynx, hypopharynx, or larynx
- ✕Prior systemic chemotherapy for the study cancer
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
In Brief
A Phase 2 clinical trial evaluating Chest Radiography, Computed Tomography, and 8 other interventions for Buccal Mucosa Squamous Cell Carcinoma and 11 related conditions. Currently recruiting, targeting 686 participants across 107 sites in 2 countries.
Signals
Detailed Summary
This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavity cancer. Sentinel lymph node biopsy surgery is a procedure that removes a smaller number of lymph nodes from your neck because it uses an imaging agent to see which lymph nodes are most likely to have cancer. Standard neck dissection, such as elective neck dissection, removes many of the lymph nodes in your neck. Using sentinel lymph node biopsy surgery may work better in treating patients with early-stage oral cavity cancer compared to standard elective neck dissection.
Study Details
Timeline
Arms & Interventions
Patients receive an imaging agent via injection and undergo planar imaging and SPECT/CT over 1-2 hours. Patients then undergo SLN biopsy. Patients also undergo FDG PET/CT, CT, and/or chest x-ray at screening and during follow up.
Patients undergo standard END. Patients also undergo FDG PET/CT, CT, and/or chest x-ray at screening and during follow up.
Interventions
Undergo chest x-ray
Undergo SPECT/CT scan and FDG PET/CT or CT
Undergo FDG PET/CT
Receive imaging agent via injection
Undergo standard elective neck dissection
Undergo planar imaging
Undergo FDG PET/CT
Ancillary studies
Undergo SLN biopsy
Undergo SPECT/CT scan